Valeant’s Biggest Drug Gets a Shot at More Sales

Valeant’s top-selling drug could grow at a double-digit clip next year…at least that what a recent Deutsche Bank physician survey suggests.
Source: Barrons

Leave a Reply

Your email address will not be published.

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>